EVISTA Israel - English - Ministry of Health

evista

eli lilly israel ltd, israel - raloxifene hydrochloride - film coated tablets - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - evista is indicated for the treatment of osteoporosis in post menopausal women. evista is indicated for the prevention of osteoporosis in post menopausal women . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.

ACT RALOXIFENE TABLET Canada - English - Health Canada

act raloxifene tablet

teva canada limited - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists

APO-RALOXIFENE TABLET Canada - English - Health Canada

apo-raloxifene tablet

apotex inc - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists

Ostiral 60mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ostiral 60mg tablets

lupin healthcare (uk) ltd - raloxifene hydrochloride - oral tablet - 60mg

Evista New Zealand - English - Medsafe (Medicines Safety Authority)

evista

eli lilly and company (nz) limited - raloxifene hydrochloride 60mg equivalent to 55.7 mg raloxifene free base - film coated tablet - 60 mg - active: raloxifene hydrochloride 60mg equivalent to 55.7 mg raloxifene free base excipient: carnauba wax crospovidone lactose lactose monohydrate magnesium stearate opacode blue s-1-10537g opadry white ys-1-18027-a polysorbate 80 povidone